Dacarbazine
CAS Number
4342-03-4Synonym
DIC; (Dimethyltriazeno)imidazolecarboxamide) DTIC; NCI-C04717; NSC-45388; 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Occurrence/Use
Medicine (antineoplastic)

Cancer Potency Information
Latest Criteria: | Proposition 65 NSRLs/MADLs |
---|---|
Inhalation Unit Risk (μg/cubic meter)-1: | 1.4 E-2 |
Inhalation Slope Factor (mg/kg-day)-1: | 4.9 E+1 |
Oral Slope Factor (mg/kg-day)-1: | 4.9 E+1 |
Comments/References: |
OEHHA 1992. Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens. |
Proposition 65
Chemical Status
Cancer: | Currently listed |
---|---|
Reproductive Toxicity : | Currently listed |
Cancer
Cancer - Listing Mechanism
State's Qualified Experts
Listed as causing : | Listed as causing: Cancer |
---|---|
Date of Listing: |
Reproductive Toxicity
Listed as causing: | Developmental Toxicity |
---|---|
Developmental Toxicity | |
Date of Listing: | |
Basis for Listing : | Formally Required |
Safe Harbor Levels
No Significant Risk Level (NSRL)
0.01 µg/day
Cancer | |
Last NSRL/MADL Revision: | 1992 |
---|
Documents, Presentations, and Publications
Cancer: |
|
---|---|
Reproductive Toxicity: |
|